<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SDU-Denmark_Tour73 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SDU-Denmark/Tour73</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="BackgroundLayout"><DIV class="top bannerShadow"><DIV class="NavbarContainer"><DIV class="NavbarContainerInner"><DIV class="MenuButton" id="btnWelcome"><A class="MenuButtonLink" href="https://2015.igem.org/Team:SDU-Denmark">Welcome</A></DIV><DIV class="MenuButton" id="btnTour"><A class="MenuButtonLink" href="https://2015.igem.org/Team:SDU-Denmark/Tour10">Interactive wiki-tour</A></DIV><DIV class="MenuButton" id="btnMenu"><A class="MenuButtonLink" href="#" id="btnMenu2">Menu</A><DIV class="menuPopup"><DIV class="menuPopupContent"><DIV class="menuPopupContentInner bannerShadow"><DIV class="menuIntro"><DIV class="warningBox"><P class="menuIntro">
You really should try our <A href="https://2015.igem.org/Team:SDU-Denmark/Tour10">interactive wiki tour</A> instead! 

</P></DIV><P class="menuIntro">
But if you are looking for a specific page - you are in the right place. 
</P><DIV class="menuItems"><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour10">Introduction</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour11">The Team</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour12">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour13">Gallery</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour14">Medal Requirements</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour20"> Antibody Issue</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour21">Antibody Production</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour22">Animal Ethics</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour23">The Alternative</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour30">PAST</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour31">Two-Hybrid Screening</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour32">System Design</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour33">Business</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour34">Entrepreneurship</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour40">Process</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour41">Complete Journal</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour42">Collaborations</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour43">SOPs</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour44">Safety</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour50">Results</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour51">Characterization</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour52">Two-Hybrid System</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour53">Submitted Parts</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour54">Interlab Study</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour60">Practices</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour61">Survey</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour62">Education</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour63">Ethics</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour64">A Children's Book</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour70">
What is Next?</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour71">Challenges and Limitations</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour72">Medical Aspects</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour72">Lab Work</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour73">The End</A></LI></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV><DIV class="tourBoundingBox"><DIV class="tourBoundingBoxInner bannerShadow"><DIV class="parentTourItem "><A class="tourItemLabel" title="Get a brief overview of the project.">
                Introduction
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="Would you like to meet our team?">
                       The Team
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="To express our thankfulness.">
                        Attributions
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Gallery
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Medal Requirements
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
               Antibody issue
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                       Antibody production
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Animal Ethics
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        The Alternative
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
                PAST            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Two-Hybrid Screening
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        System Design
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Business
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                       Entrepreneurship
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
                Process
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Complete Journal
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Collaborations
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                       SOPs
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Safety
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">       Results
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Characterization
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                      Two-Hybrid System
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                       Submitted Parts
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Interlab Study
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
Practices
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Survey
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Education
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Ethics
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title=""> A Children’s Book
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
               What is Next
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Challenges and Limitations
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Medical Aspects
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Lab Work
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                      The End
                    </A></DIV></DIV></DIV></DIV></DIV><DIV class="MainLayout"><DIV class="content"><P><I> &quot;The future belongs to those who believe in the beauty of their dreams.&quot; - <B>Eleanor Roosevelt</B></I></P><H1 align="center"> Future Laboratory  Work </H1><P><SPAN class="intro">After a screen with the nucleotide library </SPAN> and finding a peptide aptamer against a target protein the next step would be to examine the features of it.
</P><P><SPAN class="intro">The peptide aptamers affinity and specificity </SPAN> towards its target are two important parameters to know, especially if it is meant for use in diagnostics and treatment.
</P><P><SPAN class="intro">The affinity is especially important </SPAN> if we should get more than one positive colony in a screen. Several ways exist, to where we can test this, here amongs competitive Enzyme-Linked Immunosorbent Assay (ELISA). The ELISA wells would be coated with the target protein, to this we will add the peptide aptamer, giving them time to bind. After binding we will wash out any unbound peptide aptamers. A detection molecule that binds to the peptide aptamer though anti-FLAG will be added and later excess detection molecule will be washed out. An enzyme that converts the detections molecule to a color will be added. The color change or the amount of light emitted is proportional to the level of peptide aptamer bound to tar<SPAN class="sourceReference">get</SPAN>.
<SPAN class="tooltip"><SPAN class="tooltipHeader">Reference:</SPAN>
    Technical Guide for ELISA. Available from KPL, Kirkegaard &amp; Perry Laboratories. <A target="blank_" href="http://www.kpl.com/docs/techdocs/KPL%20ELISA%20Technical%20Guide.pdf">(Link)
</A>
Accessed 17 September 2015
</SPAN>


Thus the amount of peptide aptamer bound to target protein, provides a measurement for the affinity.
The ELISA is competitive, thus the amount of target is realavlively small compared to that of peptide aptamers, this means the peptide aptamers will have to “compete” for binding the target protein.
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:185px;height:200px;"><DIV class="thumbcaption">Figure 1: Illustrates the detector with the Sensor chip, as the aqueous solution containing the target proteins flows by.
</DIV></DIV></DIV><P><SPAN class="intro">Surface Plasmon Resonance (SPR) </SPAN> is a technology designed by Biacore and could be used to investigate the affinity and the specificity of the peptide aptamer.  Central for the SPR method is the movable sensor chip. This chip monitors the interaction between the peptide aptamer and its target. The operation of the instrument, data and the analysis of the data will be handled by a software.
The sensor chip consist of a glass surface covered with a thin layer of gold, which forms a good basis to optimize the binding of a variety of molecules. To this chip the peptide aptamer would be bound.
The target proteins will pass over the surface of the chip in a continuous, pulse-free and controlled flow, maintaining constant target protein concentration at the sensor chip surface.  
SPR measures changes in refractive index, thus senses changes in mass in the aqueous layer close to the sensor c<SPAN class="sourceReference">hip</SPAN>.
<SPAN class="tooltip"><SPAN class="tooltipHeader">Reference:</SPAN>
    An Introduction to BiaCore's SPR Technology. Available from BiaCore.com <A target="blank_" href="http://www.rci.rutgers.edu/~longhu/Biacore/pdf_files/SPR_Technology_Brochure.pdf">(Link)
</A>
Accessed 17 September 2015
</SPAN>
Figure 1 illustrates the principle.  This method would besides providing quantitative information of the peptide aptamers affinity towards the target, also provides information of its specificity.
</P><P><SPAN class="intro">Since we have been working with <I>E. coli</I> BTH101</SPAN>, a β-Galactosidase Assay would also be an option for examine the affinity of the peptide aptamer towards the target. The assay exploits β –Galactosidase’s ability to recognize the synthetic compound o-nitrophenyl-β-D-galactoside (ONPG). The enzyme cleaves ONPG to galactose and o-nitrophenol, which has a yellow color. The production of yellow color can be used to determine the concentration of the enzyme, since when ONPG is in excess to the enzyme, the production of o-nitrophenol is proportional to the concentration of β-Galactosidase. From the assay, the miller unit can be determined. The miller unit for a known interaction in the system, e.g. our control with the Leuzine Zipper, could be used as a stand that peptide aptamers-target interaction could be compared <SPAN class="sourceReference">to</SPAN>.
<SPAN class="tooltip"><SPAN class="tooltipHeader">Reference:</SPAN>
    Open WetWare contributors, &quot;Beta-Galactosidase Assay (A better Miller),&quot; <I>Open WetWare</I>27 August 2012, 23:20 UTC.  <A target="blank_" href="http://openwetware.org/wiki/Beta-Galactosidase_Assay_(A_better_Miller)">http://openwetware.org/wiki/Beta-Galactosidase_Assay_(A_better_Miller)
</A>
Accessed 17 September 2015.
</SPAN></P><P><SPAN class="intro">The peptide aptamer’s specificity </SPAN> could be examined with protein microarray. Many different proteins would be immoblized to the microarry chip, the peptid aptamer taged with flourecent dye though anti-FLAG, would be added. Thus the fewer proteins towards the peptid aptamer can bind, the higher specificity.
</P></DIV><DIV class="footer "><DIV class="footerContainer"><A class="footerBtn footerShadow" id="btnFastForward"><P class="footerBtnPre">Next chapter
</P></A><A class="footerBtn footerShadow" id="btnNextChapter"><P class="footerBtnPre">Next chapter
</P></A><A class="footerBtn footerShadow" id="btnDigDeeper"><P class="footerBtnPre">Dig deeper
</P></A><A class="footerBtn footerShadow" id="btnTheEnd" href="http://www.igem.org" target="_blank"><P class="footerBtnPre">End of tour
</P><P class="footerBtnHeader" style="text-transform: none !important;">Want more? Go to iGEM.org!</P><P class="footerBtnText">
If you want to learn more about Synthetic Biology you should visit iGEM's homepage, which contains loads on the subject. You can even visit other teams' wikis and take a look at what they accomplished. Or maybe join a team yourself?</P></A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>